Slide BG

March 4-5, 2016    |   San Francisco, CA

EAST MEETS WEST! The CMHC is expanding in the spring of 2016. Join us for the inaugural CMHC West focused on Novel Approaches to Integrated Cardiometabolic Disease Management, March 4-5, 2016 in San Francisco, CA. This unique, forward-thinking program will feature innovation and advancements in lifestyle medicine, therapies, technologies, patient engagement, genomics and “big data” that are driving improvements in outcomes, quality and CVD prevention. Learn More

Slide BG

11th Annual
CMHC Boston - 2016

October 5-8, 2016    |   Boston, MA

Integrated management of all aspects of cardiometabolic risk is the only way to approach the rapidly growing epidemic of cardiovascular and metabolic disease. The Cardiometabolic Health Congress provides a one-of-a-kind opportunity to stay informed on the latest scientific and clinical developments in these overlapping disease areas through a comprehensive and integrated agenda

Learn More
CMHC

11th Annual
Cardiometabolic
Health Congress

October 5-8, 2016
Boston, MA

Register Now

AT THE INTERSECTION OF
METABOLIC & CVD PREVENTION

The CMHC delivers a trifecta of medical education: superb enthusiastic speakers, cutting-edge science, and deep clinical insight that improves patient care. This is a conference that changes how you practice medicine. Read More

Online CME Activities

Did you miss the
Cardiometabolic Health Congress?

24-7 Access to Virtual Highlights & Mobile CME

VIEW ONLINE COURSES Doctor BG

What your colleagues are saying...

testimonials

"This conference has it all, from emerging research to the latest clinical guidelines to putting that knowledge into everyday practice."

Atul Soreng, MD

"As a seasoned clinician, the CMHC is the best clinical practice educational conference I've ever attended!"

Nancy Allison, ARNP, CDE

More

Stay Connected

Your information stays private with us.
We will not share it with anyone else.

Speaker Spotlight

Jeffrey M. Friedman, MD, PhD

Professor, Rockefeller University
Senior Investigator
Howard Hughes Medical Institute
New York, NY

It was Dr. Jeffrey Friedman's laboratory that originally identified the hormonal signal leptin and its receptors. At CMHC 2015 Dr. Friedman reviewed how leptin regulates body weight, how leptin was identified, and how it may be used to treat obese patients with low leptin levels. He also discussed the role of leptin in treating low-leptin diabetes/lipodystrophy and explored the hypothesis that normal-weight "metabolically obese" patients likely have a polygenic form of lipodystrophy.

View Video Highlights

Latest News

CME Virtual Highlights

CME Challenge

Introducing the Best of CMHC Virtual Highlights program, featuring video interviews with our premier faculty recorded at the Best of CMHC Regional Meeting Series in 2015. This complimentary CME/CE 1.75 hour activity presents 4 video modules, with transcript and downloadable slides.

Learn More